For: | Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v27/i43/7462.htm |
Number | Citing Articles |
1 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
2 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308: 120974 doi: 10.1016/j.lfs.2022.120974
|
3 |
Attila Kovács, Peter Bischoff, Hathal Haddad, Willi Zhou, Susanne Temming, Andreas Schäfer, Hannah Spallek, Lucas Kaupe, György Kovács, Michael Pinkawa. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. Journal of Personalized Medicine 2022; 12(3): 430 doi: 10.3390/jpm12030430
|
4 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
Abstract(127) |
Core Tip(98) |
Full Article(HTML)(1234)
|
Full Article (PDF)-1407K(209)
|
Full Article (Word)-619K(53)
|
Audio-1822K(4)
|
Peer-Review Report-260K(39)
|
Answering Reviewers-291K(44)
|
Times Cited (0)
|
Total Visits (2607)
|
Open
|
5 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
Abstract(42) |
Core Tip(33) |
Full Article(HTML)(251)
|
Full Article (PDF)-2372K(54)
|
Full Article (Word)-496K(6)
|
Audio-198K(0)
|
Peer-Review Report-222K(7)
|
Answering Reviewers-86K(4)
|
Times Cited (0)
|
Total Visits (709)
|
Open
|
6 |
Pan Liu, Xu Zhang, Qiang Fu, ChuanJiang Liu, QianKun Luo, PengFei Yu, Song Chen, HongWei Zhang, Tao Qin, Yuanwei Zhang. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/9313680
|
7 |
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Yingmin Yao, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Biochemical and Biophysical Research Communications 2023; 638: 210 doi: 10.1016/j.bbrc.2022.11.046
|
8 |
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 2022; : 909 doi: 10.2147/IJN.S349426
|